Sensus Healthcare Study Shows SRT-100® Prevents Keloid Recurrence at Taiwan’s Tri-Service Military Hospital Sensus Healthcare, Inc. (Nasdaq: SRTS), a leading medical device company focused on providing effective, non-invasive, and cost-efficient treatments for both oncological and non-oncological skin conditions, has announced…
InductiveHealth Partners with Origami Risk to Modernize Public Health Surveillance InductiveHealth, a leading provider of disease and syndromic surveillance systems and services, has announced an exclusive partnership with Origami Risk, a global leader in risk, safety, and insurance Software as…
Epredia Gets FDA 510(K) Clearance for E1000 Dx™ Digital Pathology Solution Epredia, a global leader in precision cancer diagnostics and a subsidiary of PHC Holdings Corporation, announced today that it has received U.S. Food and Drug Administration (FDA) 510(K) clearance…
Ntracts Acquires Compliatric to Enhance Healthcare Compliance Support Ntracts, a leader in contract lifecycle management (CLM) solutions for the healthcare industry, announced today the acquisition of Compliatric, a provider of regulatory, accreditation, and compliance management technology for healthcare organizations. This…
FDA Grants Orphan and Pediatric Designations to NEU-001 for Hirschsprung’s Disease Neurenati Therapeutics Inc., a biotechnology company dedicated to pediatric rare diseases, is excited to announce that the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug and…
TEVIMBRA Approved in U.S. for Advanced Esophageal Cancer with Chemotherapy BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company set to change its name to BeOne Medicines Ltd., today announced that the U.S. Food and Drug Administration…
Centauri Therapeutics Selects First Clinical Candidate for Gram-Negative Infection Treatment Centauri Therapeutics Limited, an immunotherapy company leveraging its unique Alphamer® platform technology, has announced the selection of its first clinical candidate in the ABX-01 program. This groundbreaking compound is designed…
Sofinnova Partners Raises €1.2 Billion to Drive Life Sciences Innovation Sofinnova Partners, a leading European venture capital firm specializing in life sciences, has announced the successful raising of €1.2 billion over the past year across its diverse investment strategies. This…
SFI Health™ Launches Equazen® Supplements in Portugal for Cognitive Support SFI Health™ EMEA, the regional arm of SFI Health™, a global leader in natural healthcare, is excited to announce the upcoming launch of Equazen® products in Portugal. SFI Health™ is…
Children’s of Alabama Completes 150+ Sedation-Free TNEs Using EvoEndo System EvoEndo®, Inc. (EvoEndo) is proud to announce that Children’s of Alabama has successfully completed over 150 Sedation-Free Transnasal Endoscopies (TNEs) using the EvoEndo® Single-Use Endoscopy System. This makes Children’s of…
Osivax Secures Funding to Advance Influenza Vaccine Development Osivax, a biopharmaceutical company focused on developing vaccines for broad-spectrum protection against rapidly mutating respiratory viruses, has announced the successful first close of its Series B funding round, securing €10 million from…
Actio Biosciences Doses First Participant in Phase 1 Trial of ABS-0871 for CMT2C Actio Biosciences, a clinical-stage biotechnology company focused on using its “one to many” paradigm in genetics and precision medicine, has announced that the first participant has been…